Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors
2012 ◽
Vol 52
(2-4)
◽
pp. 123-129
◽
2020 ◽
Vol 13
(1)
◽
pp. 92-101
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 37
(5)
◽
pp. 1117-1128
◽
2010 ◽
Vol 16
(4)
◽
pp. 1216-1225
◽
2017 ◽
Vol 03
(01)
◽
pp. E13-E24
◽